Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Uday S. Ganapathy, Véronique Dartois & Thomas Dick. (2019) Repositioning rifamycins for Mycobacterium abscessus lung disease. Expert Opinion on Drug Discovery 14:9, pages 867-878.
Read now
Read now
Vojo Deretic & Graham S. Timmins. (2019) Enhancement of lung levels of antibiotics by ambroxol and bromhexine. Expert Opinion on Drug Metabolism & Toxicology 15:3, pages 213-218.
Read now
Read now
Mario Malerba & Beatrice Ragnoli. (2008) Ambroxol in the 21st century: pharmacological and clinical update. Expert Opinion on Drug Metabolism & Toxicology 4:8, pages 1119-1129.
Read now
Read now
M. D. Lee, E. Ayanoglu & L. Gong. (2006) Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions. Xenobiotica 36:10-11, pages 1013-1080.
Read now
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Read now
Articles from other publishers (19)
Sergey L. Babak, Marina V. Gorbunova & Andrey G. Malyavin. (2023) Rational mucolytic therapy with ambroxol: controversial and indisputable. A review. Consilium Medicum 25:9, pages 623-628.
Crossref
Crossref
Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede & Anil Kumar Saxena. (2022) Repurposing of Chemotherapeutics to Combat COVID-19. Current Topics in Medicinal Chemistry 22:32, pages 2660-2694.
Crossref
Crossref
Pritam D. Sonawane, Suraj R. Chaudhari, Saurabh B. Ganorkar, Amod S. Patil & Atul A. Shirkhedkar. (2022) A brief review on critical analytical aspects for quantification of ambroxol in biological samples. Analytical Biochemistry 657, pages 114888.
Crossref
Crossref
Hao Zhou, Min Zhang, Ling Sun, Wenfang Li & Qian Liu. (2021) A simple LC-MS/MS method for simultaneous determination of cilostazol and ambroxol in Sprague-Dawley rat plasma and its application to drug-drug pharmacokinetic interaction study following oral delivery in rats. Journal of Chromatography B 1179, pages 122766.
Crossref
Crossref
Chao-Nan Yang, Wen-Ya Peng, Lie-Chwen Lin & Tung-Hu Tsai. (2021) Protein unbound pharmacokinetics of ambroxol in the blood and brains of rats and the interaction of ambroxol with Polygala tenuifolia by multiple microdialysis. Journal of Ethnopharmacology 269, pages 113764.
Crossref
Crossref
K. A. Zagorodnikova, K. B. Mirzaev & D. A. Sychev. (2020) Possibility for the use of bromhexine to prevent infection with SARS-CoV-2. Kachestvennaya klinicheskaya praktika:4S, pages 8-10.
Crossref
Crossref
Yasushi Yamazoe, Takahiro Goto & Masahiro Tohkin. (2020) Versatile applicability of a grid-based CYP3A4 Template to understand the interacting mechanisms with the small-size ligands; part 3 of CYP3A4 Template study. Drug Metabolism and Pharmacokinetics 35:3, pages 253-265.
Crossref
Crossref
Yoon-Myung Kim, Mi-Sun Yum, Sun Hee Heo, Taeho Kim, Hee Kyung Jin, Jae-sung Bae, Go Hun Seo, Arum Oh, Hee Mang Yoon, Hyun Taek Lim, Hyo-Won Kim, Tae-Sung Ko, Hyeong‐Seok Lim, Mark J Osborn, Jakub Tolar, Claudia Cozma, Arndt Rolfs, Ari Zimran, Beom Hee Lee & Han-Wook Yoo. (2020) Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsy. Journal of Medical Genetics 57:2, pages 124-131.
Crossref
Crossref
Maria A. Grishina & Vladimir A. Potemkin. (2019) Topological Analysis of Electron Density in Large Biomolecular Systems. Current Drug Discovery Technologies 16:4, pages 437-448.
Crossref
Crossref
Seong Won Choi, Yuexi Gu, Ryan Scott Peters, Padmini Salgame, Jerrold J. Ellner, Graham S. Timmins & Vojo Deretic. (2018) Ambroxol Induces Autophagy and Potentiates Rifampin Antimycobacterial Activity. Antimicrobial Agents and Chemotherapy 62:9.
Crossref
Crossref
Jinjun Wu, Zaixing Cheng, Shugui He, Jian Shi, Shuqiang Liu, Guiyu Zhang, Lijun Zhu, Liang Liu, Zhongqiu Liu, Na Lin & Linlin Lu. (2015) Pinelliae Rhizoma, a Toxic Chinese Herb, Can Significantly Inhibit CYP3A Activity in Rats. Molecules 20:1, pages 792-806.
Crossref
Crossref
Xin Zhou, Liang Li, Pan Deng, Xiaoyan Chen & Dafang Zhong. (2013) Characterization of metabolites of GLS4 in humans using ultrahigh‐performance liquid chromatography/quadrupole time‐of‐flight mass spectrometry. Rapid Communications in Mass Spectrometry 27:21, pages 2483-2492.
Crossref
Crossref
Jia Liu. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
3
.
Bachir Latli, Matt Hrapchak, Heinz‐Karl Switek, Daniel M. Retz, Dhileepkumar Krishnamurthy & Chris H. Senanayake. (2009) Synthesis of labeled ambroxol and its major metabolites. Journal of Labelled Compounds and Radiopharmaceuticals 53:1, pages 15-23.
Crossref
Crossref
Vladimir A. Potemkin, Alexander A. Pogrebnoy & Maria A. Grishina. (2009) Technique for Energy Decomposition in the Study of “Receptor-Ligand” Complexes. Journal of Chemical Information and Modeling 49:6, pages 1389-1406.
Crossref
Crossref
M. A. Grishina, V. A. Potemkin, A. A. Pogrebnoi & N. N. Ivshina. (2009) A study of conformational states of substrates of isoform 3A4 of cytochrome P450. Biophysics 53:5, pages 355-360.
Crossref
Crossref
Fazlul Huq. (2008) Molecular Modelling Analysis of the Metabolism of Ambroxol. Journal of Pharmacology and Toxicology 3:2, pages 147-152.
Crossref
Crossref
Tomasz Drewa, Bartosz Misterek, Hanna Pachnowska, Zbigniew Wolski, Magdalena Mikulska‐Jovanovic & Joanna Drewa. (2007) Parenteral ambroxol treatment causes xanthine and calcium oxalate stones in rats. International Journal of Urology 14:5, pages 463-465.
Crossref
Crossref
. (2006) Effect of Clarithromycin on the Pharmacokinetics of Ambroxol in Rats. Journal of Korean Pharmaceutical Sciences 36:3, pages 157-160.
Crossref
Crossref